Cadherin-17 induces tumorigenesis and lymphatic metastasis in gastric cancer through activation of NFκB signaling pathway

References

• Hartgrink HH, Jansen EP, van Grieken NC, van de Velde CJ. Gastric cancer. Lancet 2009; 374:477 - 90; http://dx.doi.org/10.1016/S0140-6736(09)60617-6; PMID: 19625077
   PubMed Web of Science ®Google Scholar
• Reshamwala PA, Darwin PE. Endoscopic management of early gastric cancer. Curr Opin Gastroenterol 2006; 22:541 - 5; http://dx.doi.org/10.1097/01.mog.0000239870.04457.80; PMID: 16891887
   PubMed Web of Science ®Google Scholar
• Catalano V, Labianca R, Beretta GD, Gatta G, de Braud F, Van Cutsem E. Gastric cancer. Crit Rev Oncol Hematol 2009; 71:127 - 64; http://dx.doi.org/10.1016/j.critrevonc.2009.01.004; PMID: 19230702
   PubMed Web of Science ®Google Scholar
• Yokota T, Ishiyama S, Saito T, Teshima S, Narushima Y, Murata K, et al. Lymph node metastasis as a significant prognostic factor in gastric cancer: a multiple logistic regression analysis. Scand J Gastroenterol 2004; 39:380 - 4; http://dx.doi.org/10.1080/00365520310008629; PMID: 15125471
   PubMed Web of Science ®Google Scholar
• Oñate-Ocaña LF, Méndez-Cruz G, Hernández-Ramos R, Becker M, Carrillo JF, Herrera-Goepfert R, et al. Experience of surgical morbidity after palliative surgery in patients with gastric carcinoma. Gastric Cancer 2007; 10:215 - 20; http://dx.doi.org/10.1007/s10120-007-0437-4; PMID: 18095076
   PubMed Web of Science ®Google Scholar
• Namikawa T, Kitagawa H, Iwabu J, Okabayashi T, Sugimoto T, Kobayashi M, et al. Clinicopathological properties of the superficial spreading type early gastric cancer. J Gastrointest Surg 2010; 14:52 - 7; http://dx.doi.org/10.1007/s11605-009-1059-4; PMID: 19821002
   PubMed Web of Science ®Google Scholar
• Kim JH, Park JM, Jung CW, Park SS, Kim SJ, Mok YJ, et al. The significances of lymph node micrometastasis and its correlation with E-cadherin expression in pT1-T3N0 gastric adenocarcinoma. J Surg Oncol 2008; 97:125 - 30; http://dx.doi.org/10.1002/jso.20937; PMID: 18095267
   PubMed Web of Science ®Google Scholar
• Kim JH, Park SS, Park SH, Kim SJ, Mok YJ, Kim CS, et al. Clinical significance of immunohistochemically-identified lymphatic and/or blood vessel tumor invasion in gastric cancer. J Surg Res 2010; 162:177 - 83; http://dx.doi.org/10.1016/j.jss.2009.07.015; PMID: 20031164
   PubMed Web of Science ®Google Scholar
• Arigami T, Natsugoe S, Uenosono Y, Yanagita S, Ehi K, Arima H, et al. Vascular endothelial growth factor-C and -D expression correlates with lymph node micrometastasis in pN0 early gastric cancer. J Surg Oncol 2009; 99:148 - 53; http://dx.doi.org/10.1002/jso.21228; PMID: 19117016
   PubMed Web of Science ®Google Scholar
• Yasui W, Oue N, Sentani K, Sakamoto N, Motoshita J. Transcriptome dissection of gastric cancer: identification of novel diagnostic and therapeutic targets from pathology specimens. Pathol Int 2009; 59:121 - 36; http://dx.doi.org/10.1111/j.1440-1827.2009.02329.x; PMID: 19261089
   PubMed Web of Science ®Google Scholar
• Yasui W, Oue N, Ito R, Kuraoka K, Nakayama H. Search for new biomarkers of gastric cancer through serial analysis of gene expression and its clinical implications. Cancer Sci 2004; 95:385 - 92; http://dx.doi.org/10.1111/j.1349-7006.2004.tb03220.x; PMID: 15132764
   PubMed Web of Science ®Google Scholar
• Wang XQ, Luk JM, Leung PP, Wong BW, Stanbridge EJ, Fan ST. Alternative mRNA splicing of liver intestine-cadherin in hepatocellular carcinoma. Clin Cancer Res 2005; 11:483 - 9; PMID: 15701831
   PubMed Web of Science ®Google Scholar
• Hinoi T, Lucas PC, Kuick R, Hanash S, Cho KR, Fearon ER. CDX2 regulates liver intestine-cadherin expression in normal and malignant colon epithelium and intestinal metaplasia. Gastroenterology 2002; 123:1565 - 77; http://dx.doi.org/10.1053/gast.2002.36598; PMID: 12404231
   PubMed Web of Science ®Google Scholar
• Ito R, Oue N, Yoshida K, Kunimitsu K, Nakayama H, Nakachi K, et al. Clinicopathological significant and prognostic influence of cadherin-17 expression in gastric cancer. Virchows Arch 2005; 447:717 - 22; http://dx.doi.org/10.1007/s00428-005-0015-2; PMID: 16044349
   PubMed Web of Science ®Google Scholar
• Ko S, Chu KM, Luk JM, Wong BW, Yuen ST, Leung SY, et al. Overexpression of LI-cadherin in gastric cancer is associated with lymph node metastasis. Biochem Biophys Res Commun 2004; 319:562 - 8; http://dx.doi.org/10.1016/j.bbrc.2004.04.197; PMID: 15178443
   PubMed Web of Science ®Google Scholar
• Okayama H, Kumamoto K, Saitou K, Hayase S, Kofunato Y, Sato Y, et al. CD44v6, MMP-7 and nuclear Cdx2 are significant biomarkers for prediction of lymph node metastasis in primary gastric cancer. Oncol Rep 2009; 22:745 - 55; PMID: 19724852
   PubMed Web of Science ®Google Scholar
• Suh YS, Lee HJ, Jung EJ, Kim MA, Nam KT, Goldenring JR, et al. The combined expression of metaplasia biomarkers predicts the prognosis of gastric cancer. Ann Surg Oncol 2012; 19:1240 - 9; http://dx.doi.org/10.1245/s10434-011-2125-1; PMID: 22048633
   PubMed Web of Science ®Google Scholar
• Lee HJ, Nam KT, Park HS, Kim MA, Lafleur BJ, Aburatani H, et al. Gene expression profiling of metaplastic lineages identifies CDH17 as a prognostic marker in early stage gastric cancer. Gastroenterology 2010; 139:213 - 25, e3; http://dx.doi.org/10.1053/j.gastro.2010.04.008; PMID: 20398667
   PubMed Web of Science ®Google Scholar
• Wang J, Yu JC, Kang WM, Wang WZ, Liu YQ, Gu P. The predictive effect of cadherin-17 on lymph node micrometastasis in pN0 gastric cancer. Ann Surg Oncol 2012; 19:1529 - 34; http://dx.doi.org/10.1245/s10434-011-2115-3; PMID: 22009269
   PubMed Web of Science ®Google Scholar
• Lin Y, Bai L, Chen W, Xu S. The NF-kappaB activation pathways, emerging molecular targets for cancer prevention and therapy. Expert Opin Ther Targets 2010; 14:45 - 55; http://dx.doi.org/10.1517/14728220903431069; PMID: 20001209
   PubMed Web of Science ®Google Scholar
• Karin M. Nuclear factor-kappaB in cancer development and progression. Nature 2006; 441:431 - 6; http://dx.doi.org/10.1038/nature04870; PMID: 16724054
   PubMed Web of Science ®Google Scholar
• Pikarsky E, Porat RM, Stein I, Abramovitch R, Amit S, Kasem S, et al. NF-kappaB functions as a tumour promoter in inflammation-associated cancer. Nature 2004; 431:461 - 6; http://dx.doi.org/10.1038/nature02924; PMID: 15329734
   PubMed Web of Science ®Google Scholar
• Flister MJ, Wilber A, Hall KL, Iwata C, Miyazono K, Nisato RE, et al. Inflammation induces lymphangiogenesis through up-regulation of VEGFR-3 mediated by NF-kappaB and Prox1. Blood 2010; 115:418 - 29; http://dx.doi.org/10.1182/blood-2008-12-196840; PMID: 19901262
   PubMed Web of Science ®Google Scholar
• Hayden MS, Ghosh S. Signaling to NF-kappaB. Genes Dev 2004; 18:2195 - 224; http://dx.doi.org/10.1101/gad.1228704; PMID: 15371334
   PubMed Web of Science ®Google Scholar
• Hartsock A, Nelson WJ. Adherens and tight junctions: structure, function and connections to the actin cytoskeleton. Biochim Biophys Acta 2008; 1778:660 - 9; PMID: 17854762
   PubMed Web of Science ®Google Scholar
• Ko S, Chu KM, Luk JM, Wong BW, Yuen ST, Leung SY, et al. CDX2 co-localizes with liver-intestine cadherin in intestinal metaplasia and adenocarcinoma of the stomach. J Pathol 2005; 205:615 - 22; http://dx.doi.org/10.1002/path.1741; PMID: 15732140
   PubMed Web of Science ®Google Scholar
• Lee NP, Poon RT, Shek FH, Ng IO, Luk JM. Role of cadherin-17 in oncogenesis and potential therapeutic implications in hepatocellular carcinoma. Biochim Biophys Acta 2010; 1806:138 - 45; PMID: 20580775
   PubMed Web of Science ®Google Scholar
• Wang XQ, Luk JM, Garcia-Barcelo M, Miao X, Leung PP, Ho DW, et al. Liver intestine-cadherin (CDH17) haplotype is associated with increased risk of hepatocellular carcinoma. Clin Cancer Res 2006; 12:5248 - 52; http://dx.doi.org/10.1158/1078-0432.CCR-06-0558; PMID: 16951245
   PubMed Web of Science ®Google Scholar
• Kaposi-Novak P, Lee JS, Gòmez-Quiroz L, Coulouarn C, Factor VM, Thorgeirsson SS. Met-regulated expression signature defines a subset of human hepatocellular carcinomas with poor prognosis and aggressive phenotype. J Clin Invest 2006; 116:1582 - 95; http://dx.doi.org/10.1172/JCI27236; PMID: 16710476
   PubMed Web of Science ®Google Scholar
• Liu LX, Lee NP, Chan VW, Xue W, Zender L, Zhang C, et al. Targeting cadherin-17 inactivates Wnt signaling and inhibits tumor growth in liver carcinoma. Hepatology 2009; 50:1453 - 63; http://dx.doi.org/10.1002/hep.23143; PMID: 19676131
   PubMed Web of Science ®Google Scholar
• Liu QS, Zhang J, Liu M, Dong WG. Lentiviral-mediated miRNA against liver-intestine cadherin suppresses tumor growth and invasiveness of human gastric cancer. Cancer Sci 2010; 101:1807 - 12; http://dx.doi.org/10.1111/j.1349-7006.2010.01600.x; PMID: 20500517
   PubMed Web of Science ®Google Scholar
• Zhang J, Liu QS, Dong WG. Blockade of proliferation and migration of gastric cancer via targeting CDH17 with an artificial microRNA. Med Oncol 2011; 28:494 - 501; http://dx.doi.org/10.1007/s12032-010-9489-0; PMID: 20393816
   PubMed Web of Science ®Google Scholar
• Yu YY, Li Q, Zhu ZG. NF-kappaB as a molecular target in adjuvant therapy of gastrointestinal carcinomas. Eur J Surg Oncol 2005; 31:386 - 92; http://dx.doi.org/10.1016/j.ejso.2004.10.010; PMID: 15837045
   PubMed Web of Science ®Google Scholar
• Beinke S, Ley SC. Functions of NF-kappaB1 and NF-kappaB2 in immune cell biology. Biochem J 2004; 382:393 - 409; http://dx.doi.org/10.1042/BJ20040544; PMID: 15214841
   PubMed Web of Science ®Google Scholar
• Dolcet X, Llobet D, Pallares J, Matias-Guiu XNF. NF-kB in development and progression of human cancer. Virchows Arch 2005; 446:475 - 82; http://dx.doi.org/10.1007/s00428-005-1264-9; PMID: 15856292
   PubMed Web of Science ®Google Scholar
• Joukov V, Pajusola K, Kaipainen A, Chilov D, Lahtinen I, Kukk E, et al. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. EMBO J 1996; 15:290 - 8; PMID: 8617204
   PubMed Web of Science ®Google Scholar
• Shimizu K, Kubo H, Yamaguchi K, Kawashima K, Ueda Y, Matsuo K, et al. Suppression of VEGFR-3 signaling inhibits lymph node metastasis in gastric cancer. Cancer Sci 2004; 95:328 - 33; http://dx.doi.org/10.1111/j.1349-7006.2004.tb03211.x; PMID: 15072591
   PubMed Web of Science ®Google Scholar
• Oeckinghaus A, Hayden MS, Ghosh S. Crosstalk in NF-κB signaling pathways. Nat Immunol 2011; 12:695 - 708; http://dx.doi.org/10.1038/ni.2065; PMID: 21772278
   PubMed Web of Science ®Google Scholar
• Covert MW, Leung TH, Gaston JE, Baltimore D. Achieving stability of lipopolysaccharide-induced NF-kappaB activation. Science 2005; 309:1854 - 7; http://dx.doi.org/10.1126/science.1112304; PMID: 16166516
   PubMed Web of Science ®Google Scholar
• Basak S, Hoffmann A. Crosstalk via the NF-kappaB signaling system. Cytokine Growth Factor Rev 2008; 19:187 - 97; http://dx.doi.org/10.1016/j.cytogfr.2008.04.005; PMID: 18515173
   PubMed Web of Science ®Google Scholar
• Gao J. Construction of lymphatic metastasis model. In: Gao J, Zhang JB, eds. Basic and clinical research on invasion and metastasis of carcinoma. Beijing: Science press, 2003:67-74.
   Google Scholar
• Kozaki K, Miyaishi O, Tsukamoto T, Tatematsu Y, Hida T, Takahashi T, et al. Establishment and characterization of a human lung cancer cell line NCI-H460-LNM35 with consistent lymphogenous metastasis via both subcutaneous and orthotopic propagation. Cancer Res 2000; 60:2535 - 40; PMID: 10811136
   PubMed Web of Science ®Google Scholar